Skip to main content
. Author manuscript; available in PMC: 2022 Feb 15.
Published in final edited form as: Expert Opin Drug Saf. 2018 Dec 26;18(1):21–27. doi: 10.1080/14740338.2019.1561857

Table 1.

Comparison of different study designs used to monitor the safety of rotavirus vaccines with respect to intussusception.

Study Design Strengths Weaknesses
Randomized Controlled Trials • Randomization minimizes selection bias and helps distribute potential confounders equally
• Rigorous follow-up of patients and strict adherence to protocol
• Large sample sizes required for rare events and/or low level risks
• Costly
• May not reflect real-world conditions
Passive Adverse Event Reporting • Can capture new or unexpected events • Expected or baseline rate of the condition, the number of children vaccinated, and completeness of reporting often unknown
Cohort Studies • Known catchment population enables calculation of rates
• Closely monitor for cases of intussusception and record vaccination status for individual cases
• Requires large sample size for rare adverse events
• Costly
• Susceptible to changes in care/treatment over time
• Cohort may not be representative of entire population
Case-Control Evaluations • Smaller sample size required
• Resource efficient
• Potential bias due to control selection and confounders
• Study team not blinded to case/control status
• Logistical challenges in enrolling controls
Self-Controlled Case-Series Evaluations • Smaller sample size required
• Resource efficient
• Controls for individual level confounders
• Complex analytic methods
Ecologic Trends • Relatively straight-forward to implement • Trends susceptible to improved surveillance and increased awareness over time especially with rare events